Business

US FDA Grants CLIA Waiver for FebriDx

US FDA Grants CLIA Waiver for FebriDx

Lumos Diagnostics Holdings Ltd.March 26, 20265
US FDA Grants CLIA Waiver for FebriDx

About this update from Lumos Diagnostics Holdings Ltd.

Lumos Diagnostics Holdings Ltd has released a press release. View Attachment

View stock analysis, news, and events for Lumos Diagnostics Holdings Ltd.

More from Lumos Diagnostics Holdings Ltd.

All Lumos Diagnostics Holdings Ltd. news →